Experiment: 2JUO

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
2	2D 1H-13C HSQC	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-10% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
3	3D CBCA(CO)NH	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
4	3D HNCO	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
5	3D HNCA	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
6	3D HNCACB	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
7	3D 1H-15N NOESY	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
8	3D 1H-15N TOCSY	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
9	3D HCCH-TOCSY	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
10	simultaneous CN NOESY	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
11	EZ-HMQC-NH2	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
12	N-CG spin echo	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
13	CO-CG spin echo	20 mM sodium phosphate, 20 mM sodium chloride, 1 mM [U-100% 13C; U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O
14	15N IPAP	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O		7.0		298.1
15	3D HNHB	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O		7.0		298.1
16	T1 T2 HNNOE	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O		7.0		298.1
17	3D HNHA	20 mM sodium phosphate, 50 mM sodium chloride, 1 mM [U-100% 15N] GABPa OST, 2 mM DTT	90% H2O/10% D2O		7.0		298.1

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	UNITY	500
2	Varian	INOVA	600
3	Varian	INOVA	800

NMR Refinement
Method	Details	Software
simulated annealing		ARIA

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	1000
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	structure solution	ARIA	1.2	Linge, O'Donoghue and Nilges
2	refinement	ARIA	1.2	Linge, O'Donoghue and Nilges
3	structure solution	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
4	refinement	CNS	1.1	Brunger, Adams, Clore, Gros, Nilges and Read
5	collection	Sparky	3.11	Goddard
6	data analysis	TALOS		Cornilescu, Delaglio and Bax
7	structure solution	MOLMOL		Koradi, Billeter and Wuthrich
8	data analysis	MOLMOL		Koradi, Billeter and Wuthrich
9	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
10	data analysis	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.